THE MAGNA GROUP PRACTICE
HIGHTHORN ROAD, KILNHURST, MEXBOROUGH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 13 | 13 | 100.0% | |
| HF 4 | 2011 | 14 | 23 | 60.9% | |
| HF 4 | 2012 | 17 | 26 | 65.4% | |
| HF 4 | 2013 | 28 | 36 | 77.8% | |
| HF004 | 2014 | 22 | 23 | 95.7% | |
| HF004 | 2015 | 20 | 21 | 95.2% | |
| HF004 | 2016 | 21 | 25 | 84.0% | |
| HF004 | 2017 | 28 | 31 | 90.3% | |
| HF004 | 2018 | 38 | 42 | 90.5% | |
| HF004 | 2019 | 49 | 57 | 86.0% | |
| HF004 | 2020 | 43 | 50 | 86.0% | |
| HF006 | 2021 | 54 | 59 | 91.5% | |
| HF006 | 2022 | 52 | 58 | 89.7% | |
| HF006 | 2023 | 56 | 56 | 100.0% |
